Role of arginine in protein refolding, solubilization, and purification
- PMID: 15458311
- DOI: 10.1021/bp0498793
Role of arginine in protein refolding, solubilization, and purification
Abstract
Recombinant proteins are often expressed in the form of insoluble inclusion bodies in bacteria. To facilitate refolding of recombinant proteins obtained from inclusion bodies, 0.1 to 1 M arginine is customarily included in solvents used for refolding the proteins by dialysis or dilution. In addition, arginine at higher concentrations, e.g., 0.5-2 M, can be used to extract active, folded proteins from insoluble pellets obtained after lysing Escherichia coli cells. Moreover, arginine increases the yield of proteins secreted to the periplasm, enhances elution of antibodies from Protein-A columns, and stabilizes proteins during storage. All these arginine effects are apparently due to suppression of protein aggregation. Little is known, however, about the mechanism. Various effects of solvent additives on proteins have been attributed to their preferential interaction with the protein, effects on surface tension, or effects on amino acid solubility. The suppression of protein aggregation by arginine cannot be readily explained by either surface tension effects or preferential interactions. In this review we show that interactions between the guanidinium group of arginine and tryptophan side chains may be responsible for suppression of protein aggregation by arginine.
Similar articles
-
Suppression of protein interactions by arginine: a proposed mechanism of the arginine effects.Biophys Chem. 2007 Apr;127(1-2):1-8. doi: 10.1016/j.bpc.2006.12.007. Epub 2006 Dec 21. Biophys Chem. 2007. PMID: 17257734 Review.
-
Biotechnology applications of amino acids in protein purification and formulations.Amino Acids. 2007 Nov;33(4):587-605. doi: 10.1007/s00726-007-0506-3. Epub 2007 Mar 16. Amino Acids. 2007. PMID: 17357829 Review.
-
Is arginine a protein-denaturant?Protein Expr Purif. 2005 Jul;42(1):1-6. doi: 10.1016/j.pep.2005.03.028. Epub 2005 Apr 19. Protein Expr Purif. 2005. PMID: 15893471 Review.
-
Estimating the potential refolding yield of recombinant proteins expressed as inclusion bodies.Biotechnol Bioeng. 2004 Sep 5;87(5):584-92. doi: 10.1002/bit.20148. Biotechnol Bioeng. 2004. PMID: 15352056
-
Refolding kinetics of denatured-reduced lysozyme in the presence of folding aids.J Biotechnol. 2004 Oct 19;114(1-2):135-42. doi: 10.1016/j.jbiotec.2004.06.012. J Biotechnol. 2004. PMID: 15464607
Cited by
-
Production and characterization of homologous protoporphyrinogen IX oxidase (PPO) proteins: Evidence that small N-terminal amino acid changes do not impact protein function.PLoS One. 2024 Sep 26;19(9):e0311049. doi: 10.1371/journal.pone.0311049. eCollection 2024. PLoS One. 2024. PMID: 39325813 Free PMC article.
-
Addition of arginine hydrochloride and proline to the culture medium enhances recombinant protein expression in Brevibacillus choshinensis: The case of RBD of SARS-CoV-2 spike protein and its antibody.Protein Expr Purif. 2022 Jun;194:106075. doi: 10.1016/j.pep.2022.106075. Epub 2022 Feb 26. Protein Expr Purif. 2022. PMID: 35231586 Free PMC article.
-
Exploring designability of electrostatic complementarity at an antigen-antibody interface directed by mutagenesis, biophysical analysis, and molecular dynamics simulations.Sci Rep. 2019 Mar 14;9(1):4482. doi: 10.1038/s41598-019-40461-5. Sci Rep. 2019. PMID: 30872635 Free PMC article.
-
Transduction of human recombinant proteins into mitochondria as a protein therapeutic approach for mitochondrial disorders.Pharm Res. 2011 Nov;28(11):2639-56. doi: 10.1007/s11095-011-0546-y. Epub 2011 Aug 27. Pharm Res. 2011. PMID: 21874377 Review.
-
Assessment of E. coli Expression System for Overexpression of Active Recombinant Ocriplasmin.Adv Pharm Bull. 2021 May;11(3):564-569. doi: 10.34172/apb.2021.065. Epub 2020 Jun 21. Adv Pharm Bull. 2021. PMID: 34513632 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources